We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Protective Agent Dramatically Cuts Post-Radiation Mucositis

By MedImaging International staff writers
Posted on 26 Sep 2018
Print article
A novel agent could dramatically reduce the incidence of severe oral mucositis in patients with head and neck cancer undergoing radiation therapy (RT), according to a new study.

Researchers at the University of Iowa (Iowa City, USA), Galera Therapeutics (Malvern, PA, USA), and other institutions conducted a study to determine whether GC4419, a superoxide dismutase mimetic (SDM) that converts superoxide to molecular oxygen (O2) and hydrogen peroxide (H2O2), could reduce the incidence, duration, and severity of radiation-induced oral mucositis. The study included 223 patients undergoing intensity modulated radiation therapy (IMRT) for locally advanced, non-metastatic squamous cell carcinoma of the head and neck, limited to the oral cavity or the oropharynx.

The patients were divided into three treatment groups; Group A received 30 mg of GC4419 per day, concurrent with daily fractions of IMRT, for a total of 60-72 Gy over approximately seven weeks, plus cisplatin administered at 80-100 mg/m2 once every three weeks, or 30-40 mg/m2 once weekly for six to seven doses. Group B received 90 mg GC4419 per day with the same protocol; and Group C received placebo daily, again with the same protocol.

The results revealed that GC4419 reduced the duration of severe radiation-induced oral mucositis by 92%. When analyzed by group, the median number of days of severe oral mucositis (grade 3 or 4) was 19 days for patients who received placebo, eight days for those who received 30 mg, and just 1.5 days for those receiving 90 mg. Beyond suffering from severe oral mucositis, the placebo group also required insertion of a gastrostomy tube for feeding. The study was presented at the American Chemical Society (ACS) annual meeting, held during August 2018 in Boston (MA, USA).

“Roughly 50% of all solid tumors are treated with radiation therapy. It has many beneficial effects, but a major side effect is inflammation, and normal tissue toxicity is the key limitation to tumor targeting,” said senior study co-author Dennis Riley, PhD, chief science officer at Galera Therapeutics. “Hydrogen peroxide is very toxic to cancer cells, so in a way we shifted the paradigm. We remove superoxide, which is toxic to normal cells, and convert it to hydrogen peroxide, which is toxic to cancer cells. So we believe we can transform radiotherapy and treatment of solid tumors.”

During RT, inflammation develops because the radiation breaks the oxygen-hydrogen (OH) bonds of water in the body, creating superoxide, which is toxic at high concentrations. Consequently, nearly all organisms living in the presence of oxygen contain SOD superoxide-scavenging enzymes. SOD has powerful antinflammatory activity, as it decreases reactive oxygen species (ROS) and oxidative stress, and thus inhibits endothelial activation.

Related Links:
University of Iowa
Galera Therapeutics

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
MRI System
uMR 588
Digital Radiography Acquisition Software
VXvue with PureImpact
Ultrasound System
P25 Elite

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

General/Advanced Imaging

view channel
Image: The Cinematic Reality app enables interaction with realistic renderings of human anatomy (Photo courtesy of Siemens)

AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning

Siemens Healthineers (Erlangen, Germany) has launched an app designed for Apple Vision Pro that allows users including surgeons, medical students, or patients to view immersive, interactive holograms of... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.